| Product Unit Size | Cost | Quantity | Stock |
|---|
Salbutamol is a short-acting agonist at β2-adrenergic receptors that is clinically used to treat asthma and chronic obstructive pulmonary disorder (COPD). Salbutamol exhibits bronchodilatory, anti-asthma, tocolytic, antioxidative, and anti-inflammatory activities. In vivo, salbutamol decreases carrageenan-induced inflammation and nociception, suppresses activity of myeloperoxidase, and increases activity of superoxide dismutase and levels of glutathione.
| Cas No. | 18559-94-9 |
|---|---|
| Purity | ≥98% |
| Formula | C13H21NO3 |
| Formula Wt. | 239.31 |
| Chemical Name | α1-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy- 1,3-benzenedimethanol |
| IUPAC Name | 4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol |
| Synonym | Albuterol, Salbutamol |
| Melting Point | 151°C OR 157-158°C |
| Solubility | Soluble in most organic solvents. |
| Appearance | White or Almost White Crystalline Powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Matsumoto K, Aizawa H, Fukuyama S, et al. Low-dose salbutamol suppresses airway responsiveness to histamine but not methacholine in subjects with asthma. Respir Investig. 2013 Sep;51(3):158-65. PMID: 23978642.
Uzkeser H, Cadirci E, Halici Z, et al. Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism. Mediators Inflamm. 2012;2012:438912. PMID: 22665951.